The prevalence of smoking among African American young adults “catches up” with other groups despite the low rate among Black youth. The ban on menthol may affect this and other aspects of smoking patterns among Black Americans.
The FDA’s ban on menthol cigarettes is expected to have a disproportionate effect on Black smokers. The FDA announcement of the ban last week said that nearly 85% of Black smokers smoke menthol cigarettes compared with 30% of White smokers. Results of a Canadian study of menthol cigarette ban in seven provinces there found that most (60%) menthol cigarette smokers switch to nonmenthol cigarettes. Even so, a sizable majority (about 20%) quit smoking. Extrapolating from that study, last week’s FDA announcement projected that the menthol ban could lead to as many as 923,000 smokers quitting, including 230,000 African Americans.
This would all seem to be good news for reducing lung cancer deaths among Black Americans. Smoking is the most leading cause of lung cancer, and lung cancer is the leading cause of cancer death in Black men and women. The American Cancer Society’s most recent Cancer Facts & Figures for African Americans report estimated that 16,550 Black Americans died from lung cancer in 2019.
The menthol ban may also have an effect on various aspects of what some researchers have called the “African American smoking paradox.” A 2016 review paper on the subject in the journal Nicotine & Tobacco Research identified four elements of the paradox:
Menthol cigarettes may explain several aspects of African American smoking paradox, Fagan and co-authors wrote. At high concentrations, menthol can reduce the irritation and sensitivity to the bitter flavor of nicotine. They point to evidence that sensitivity to bitter taste is an inherited trait and that Black Americans are more like to inherit the trait. The sensitivity to bitterness may explain low initiation and prevalence among Black young people. The sensitivity tends to wane with age, however, which in combination with the masking effects of menthol may explain why the smoking rates among Black young adults “catch up” with those for other groups.
Studies do not show that menthol causes cancer, but it may increase nicotine dependence and therefore make quitting more difficult. Fagan and her colleagues moot the possibility that menthol interacts with nicotine and makes it more available. They also mention that menthol may blunt pain signals, resulting in delayed diagnosis and care for the conditions caused by smoking.
Menthol cigarettes are just one of many possible explanations for the African American smoking paradox, Fagan and her co-authors acknowledge. But they also point to the marketing of menthol cigarettes to Black Americans: “The role of marketing of menthol cigarettes to blacks/African Americans and marketing’s role in the African American smoking paradox cannot be understated.”
Marketing messages for menthol cigarettes differed from those for nonmenthol cigarettes and increased the prevalence of smoking among African Americans and among young people and the population in general, they said.
Keytruda Plus Platinum-based Chemotherapy Comes Out on Top in Network Meta-analysis
September 27th 2021Judging by common end points such as overall survival and progression-free survival, results of a network meta-analysis show that Keytruda in combination with platinum-based chemotherapy achieves the best results among the immune checkpoint inhibitor therapies used to treat advanced nonsmall cell lung cancer.
Read More
The Mainstreaming of Targeted Lung Cancer Treatment
September 14th 2021Treatments aimed at certain mutations have proliferated and moved upstream to earlier-stage lung cancers. But there are many questions about insurance coverage and which tests to use to identify the biomarkers that help guide treatment.
Read More